The Safe Effective Light Dose of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
Condition(s):Central Serous ChorioretinopathyLast Updated:February 16, 2015Unknown status
Hide Studies Not Open or Pending
Condition(s):Central Serous ChorioretinopathyLast Updated:February 16, 2015Unknown status
Condition(s):Central Serous Chorioretinopathy; Tomography, Optical CoherenceLast Updated:April 17, 2018Completed
Condition(s):Chronic Central Serous ChorioretinopathyLast Updated:June 15, 2016Unknown status
Condition(s):Polypoidal Choroidal Vasculopathy Without Active PolypLast Updated:September 5, 2018Completed
Condition(s):Acute Central Serous ChorioretinopathyLast Updated:April 5, 2022Completed
Condition(s):Polypoidal Choroidal VasculopathyLast Updated:December 12, 2022Completed
Condition(s):Wet Age-Related Macular DegenerationLast Updated:November 14, 2008Completed
Condition(s):Neovascular Age-related Macular Degeneration; Macular DegenerationLast Updated:November 9, 2021Completed
Condition(s):Age-Related Macular DegenerationLast Updated:March 24, 2010Terminated
Condition(s):Ocular Histoplasmosis; Choroidal NeovascularizationLast Updated:October 27, 2006Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.